Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Kushen injection for prevention of radiation-induced skin injury in nasopharyngeal carcinoma
ChiCTR2100049164Phase 2Completed
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jun 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of compound kushen injection in acute radiodermatitis (ARD) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Classification of acute radiodermatitis and RISRAS score of acute radiation dermatitis. Started Jun 2014; status: completed.
02
Drugs
compound kushen injection
03
Conditions
acute radiodermatitis (ARD)
Beyond the preview
Go deeper on ChiCTR2100049164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049164.